School of Medicine


Showing 1,231-1,240 of 1,447 Results

  • Lawrence Steinman, MD

    Lawrence Steinman, MD

    George A. Zimmermann Professor and Professor of Pediatrics

    Current Research and Scholarly InterestsOur laboratory is dedicated to understanding the pathogenesis of autoimmune diseases, particularly multiple sclerosis. We have developed several new therapies for autoimmunity, including some in Phase 2 clinical trials, as well as one approved drug, natalizumab. We have developed microarray technology for detecting autoantibodies to myelin proteins and lipids. We employ a diverse range of molecular and celluar approaches to trying to understand multiple sclerosis.

  • Lindsay Stevens

    Lindsay Stevens

    Clinical Professor, Pediatrics - General Pediatrics

    Current Research and Scholarly InterestsClinical Informatics is the scientific field concerned with the application of information technology to the delivery of healthcare services. In my current role as a lead physician in this department, I work with my colleagues to evaluate the best ways to implement and optimize health information technology to benefit the patients we serve at Stanford Children's Health. Specific areas of focus include: Improving EMR education for clinicians and merging Health IT with medical education.

  • David Stevenson

    David Stevenson

    Professor of Pediatrics (Genetics)

    Current Research and Scholarly InterestsMy research focuses on disorders of the RAS/MAPK pathway (eg. NF1, Noonan, CFC, and Costello syndrome). I am working on understanding the impact of RAS signaling on the musculoskeletal system. I use genomic approaches to identify somatic events and modifiers in the RASopathies. I am also involved in identifying outcome measures for use in clinical trials for the associated orthopedic manifestations. Other areas of research involve vascular anomalies, Prader-Willi syndrome, and hypophosphatasia.

  • David K. Stevenson, M.D.

    David K. Stevenson, M.D.

    Harold K. Faber Professor of Pediatrics, Senior Associate Dean, Maternal and Child Health and Professor, by courtesy, of Obstetrics and Gynecology

    Current Research and Scholarly InterestsOur research is focused on the study of the ontogeny and control of heme catabolism and bilirubin production in the developing neonate. A better understanding of the role of increased bilirubin production in neonatal jaundice and the prevention of hemolytic jaundice has remained an overall objective of our program. We are also study the causes of preterm birth and ways to prevent it.

  • Terrell Stevenson

    Terrell Stevenson

    Clinical Assistant Professor, Pediatrics

    BioDr. Terrell Stevenson specializes in the care of hospitalized children. She works both at Stanford and Santa Clara Valley Medical Center. She has particular interests in community pediatric hospital medicine (including care of well babies and coverage of NICU/PICU patients), advocacy, the hospitalist's role in comfort care, and teaching medical trainees.

  • Christopher Stewart

    Christopher Stewart

    Affiliate, Peds/Hospital Medicine

    BioChristopher C. Stewart, MD, FAAP, is a Professor of Pediatrics at UCSF, and board certified in child abuse pediatrics. Dr. Stewart received his BA from Yale, his MD degree from Harvard University and completed his residency training in pediatrics at UCSF. He is a pediatric hospitalist at San Francisco's only trauma center, is director of the Stanford/LPCH, and UCSF Mission Bay Children’s Hospital Suspected Child Abuse and Neglect (SCAN) Teams. Dr. Stewart consults on child abuse cases for several Bay Area County hospitals, as well as consultation and testifying for Child Protective Services and District Attorney’s offices. Dr. Stewart co-directs a child abuse rotation for medical students, residents and fellows at Stanford/LPCH and UCSF. As community service, he co-directs the Child Death Review Team for San Francisco County, and sits on numerous regional county committees and CBOs related to child abuse and neglect. He is a member of the Ray Helfer Society, an honorary society of physicians seeking to provide leadership to enhance the prevention, diagnosis, and treatment of child abuse and neglect. Dr. Stewart has also been PI on several federally and state funded international research training grants. Dr. Stewart has been involved in many international projects, for which he was awarded the UCSF Chancellor’s Award for public service, has received a number of teaching awards, and has provided lectures and training in international settings, including training in the Eastern Democratic Republic of Congo and recently to Syrian doctors documenting torture cases.

  • Sarah Streett

    Sarah Streett

    Clinical Professor, Medicine - Gastroenterology & Hepatology

    BioDr. Sarah Streett is a Clinical Professor of Medicine, the Director of Inflammatory Bowel Disease Education at Stanford, and she is passionate about taking care of people with IBD. She is a national expert in treating complex IBD and initiated a multi-disciplinary approach to care with colorectal surgery, pediatrics, and nutrition. In 2018 she received the Champion of Hope Award from the Crohn’s and Colitis Foundation and serves on their National Scientific Advisory Committee. Her interests focus on fertility and pregnancy in people with IBD, developing precision approaches to IBD therapy, and the role that the microbiome and diet play in its pathogenesis. She is a primary investigator of the Stanford IBD Registry and has research projects focused on optimizing clinical outcomes in IBD, the role of the microbiota and diet in IBD and pregnancy, and applying new technologies to individualizing therapy for IBD. She is also the primary investigator on multiple industry-sponsored IBD trials.

    Teaching is a top priority for Dr. Streett who feels that mentoring fellows in the development of their careers is a privilege. She has held many national leadership roles in the American Gastroenterological Association, where she has been Chair of the Practice Management and Economics Committee, and currently serves on the Government Affairs Committee. She also an appointed member of the Gastrointestinal Drug Advisory Committee at the FDA. She has represented the interests of gastroenterologists and their patients on Capitol Hill numerous times. Dr. Streett believes strongly in a collaborative approach to give patients personalized care based on the latest therapies for the treatment of IBD and is committed to mentoring the next generation of experts in the field.